Kathleen I. Pritchard
机构: Professor, Division of Medical Oncology, University of Toronto
每年引用次数
引用次数
引用: 97,394
H-指数: 121
I10-指数 : 386
出版物: 803
Platinum containing regimens for metastatic breast cancer
Davina Ghersi , John Simes , IC Henderson , Russell Basser
Cochrane Database of Systematic Reviews ( 4)
2001
Basal biomarkers Nestin and INPP4b accurately identify intrinsic breast cancer subtype and predict benefit from anthracycline vs. non-anthracycline based treatment in the CCTG MA. 5 phase III randomized clinical trial
Karama Asleh , Dongxia Gao , Dongsheng Tu , Lois Shepherd
LABORATORY INVESTIGATION 98 46 -46
2018
Vitamin D levels, vitamin D receptor polymorphisms, and inflammatory cytokines in aromatase inhibitor-induced Arthralgias: An analysis of CCTG MA. 27
Polly Niravath , Bingshu Chen , Judy-Anne W Chapman , Sandeep K Agarwal
Clinical breast cancer 18 ( 1) 78 -87
21
2018
Early prediction of therapy responses and outcomes in breast cancer patients using textural characteristics of quantitative ultrasound spectral parametric maps
Ali Sadeghi-Naini , Lakshmanan Sannachi , Kathleen Pritchard , Maureen Trudeau
Original Reports-SUPPORTIVE CARE AND QUALITY OF LIFE-Assessment of Quality of Life in MA. 17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women
Timothy J Whelan , Paul E Goss , James N Ingle , Joseph L Pater
Journal of Clinical Oncology 23 ( 28) 6931 -6940
2005
ORIGINAL REPORTS-Hematologic Malignancies-Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group
Michael Crump , Dongsheng Tu , Lois Shepherd , Mark Levine
Journal of Clinical Oncology 21 ( 16) 3066 -3071
2003
NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP How compliant are patients with oral hormonal therapies? Data from a randomized placebo controlled study of tamoxifen (T), after adjuvant chemotherapy (CT), in premenopausal women with early breast cancer (EBC):(NCIC CTG MA. 12)
Vivien Bramwell , Kathleen Pritchard , Dongsheng Tu , Katia Tonkin
NCIC CLINICAL TRIALS GROUP (NCIC CTG) A PHASE III RANDOMIZED TRIAL OF METFORMIN VERSUS PLACEBO ON RECURRENCE AND SURVIVAL IN EARLY STAGE BREAST CANCER
Kathleen Pritchard , Timothy Whelan , Lois Shepherd , Jennifer Ligibel
The consensus conference on treatment of estrogen deficiency symptoms in women surviving breast cancer.
Richard Santen , Kathleen Pritchard , Henry Burger
Obstetrical & Gynecological Survey 53 ( 10)
23
1998
Cardiac monitoring and heart failure in advanced breast cancer patients treated with trastuzumab in Ontario, Canada
Moira Rushton , Coralea Kappel , Isac Lima , Meltem Tuna
Frontiers in Cardiovascular Medicine 9 850674 -850674
4
2022
High dose therapy with stem cell support for breast cancer: the jury is still out
Michael Crump , Kathleen Pritchard
Advances in Breast Cancer Management 115 -136
2
2000
Correction: Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach
Hadi Tadayyon , Lakshmanan Sannachi , Mehrdad Gangeh , Ali Sadeghi-Naini
Oncotarget 8 ( 21) 35481 -35481
2017
Effects of endocrine therapy on cognitive functioning in women treated for breast cancer: A meta-analysis
Emily Underwood , Kathy Zhang , Rahim Moineddin , Philip Lee
PSYCHO-ONCOLOGY 26 68 -68
2017
Re: Should observational studies be a thing of the past?-Response
Kathleen Pritchard
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 100 ( 15) 1117 -U27
2008
Discovery of apoptotic genes in the genome-wide study of doxorubicin resistance in cancer treatment
Irada Ibrahim-zada , Hamdi Jarjanazi , Sevtap Savas , Kathleen Pritchard
Cancer Research 68 ( 9_Supplement) LB -LB
2008
Current Status of Postchemotherapy Tamoxifen in Early Breast Cancer
Kathleen Pritchard
Oncology-Huntington 8 ( 11) 48 -49
1994
Postmenopausal breast cancer: is the short-term pain worth the long-term gain?
KathleenI. Pritchard
The Lancet 347 ( 9008) 1057 -1058
3
1996
Adjuvant systemic therapy for breast cancer: a tale of relapse and survival
KathleenI. Pritchard
The Lancet 343 ( 8894) 370 -371
2
1994
Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.
ElizabethA. Eisenhauer , KathleenI. Pritchard , DanieleJ. Perrault , Shailendra Verma
Investigational New Drugs 8 ( 3) 283 -287
7
1990
Abstract P6-12-01: A Meta Analysis of Risk of Cardiovascular Events in Patients with Metastatic Breast Cancer (MBC) Treated with Anti Vascular Endothelial Growth Factor (VEGF) Therapy — Bevacizumab
S Nasim , BA Sousa , RA Dent , KI. Pritchard
Cancer Research 70
3
2010